Funds holding Alto Neuroscience Inc
ISIN US02157Q1094 · United States
- Fund holders
- 44
- Of which ETFs
- 12 32 other funds
- Value held
- 62.3M $
- Share of capital
- 7.0 % of 39.2M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 875,781 | 19.7M $ | 0.00 % | 2.23 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 405,275 | 10.4M $ | 1.00 % | 1.03 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 302,323 | 6.8M $ | 0.01 % | 0.77 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 268,280 | 6M $ | 0.06 % | 0.68 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 212,677 | 4.8M $ | 0.06 % | 0.54 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 140,106 | 2.8M $ | 0.01 % | 0.36 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 73,288 | 1.6M $ | 0.54 % | 0.19 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 58,544 | 1.3M $ | 0.11 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 48,667 | 958.3K $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 41,023 | 922.2K $ | 4.55 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 38,701 | 762K $ | 0.00 % | 0.10 % | as of Feb 28, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 36,638 | 823.6K $ | 0.00 % | 0.09 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 27,688 | 545.2K $ | 0.40 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 25,000 | 562K $ | 0.46 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 23,553 | 529.5K $ | 0.62 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 16,417 | 421.3K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 16,400 | 368.7K $ | 0.06 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 15,874 | 356.8K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 12,871 | 289.3K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 12,483 | 320.3K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 12,046 | 270.8K $ | 0.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 10,917 | 280.1K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 10,216 | 201.2K $ | 0.01 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 8,369 | 188.1K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 6,745 | 151.6K $ | 0.04 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 5,900 | 132.6K $ | 0.06 % | 0.02 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 4,120 | 92.6K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 4,100 | 92.2K $ | 0.06 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 3,785 | 97.1K $ | 0.13 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 3,437 | 67.7K $ | 0.01 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 3,266 | 83.8K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 2,622 | 58.9K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 2,325 | 52.3K $ | 0.51 % | 0.01 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 2,274 | 58.4K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 2,143 | 55K $ | 0.43 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 1,813 | 46.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 1,571 | 40.3K $ | 0.78 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1,300 | 29.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 823 | 21.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 719 | 16.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 551 | 14.1K $ | 0.42 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 518 | 11.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. Social Core Equity 2 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC | 200 | 5.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 152 | 3.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| AdvisorShares Psychedelics ETF AdvisorShares Trust | 4.55 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 1.00 % | as of Apr 30, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 0.78 % | as of Apr 30, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.62 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 0.54 % | as of Mar 31, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 0.51 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.46 % | as of Mar 31, 2026 ↗ |
| Direxion Daily Pharmaceutical & Medical Bull 3X Shares Direxion Shares ETF Trust | 0.43 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 0.42 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.40 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 44 | +13 | 2,741,501 | +20.9 % |
| 2026Q1 | 31 | +11 | 2,266,859 | +22.6 % |
| 2025Q4 | 20 | -27 | 1,848,366 | -24.0 % |
| 2025Q3 | 47 | -34 | 2,431,833 | -39.4 % |
| 2025Q2 | 81 | -2 | 4,013,326 | -1.8 % |
| 2025Q1 | 83 | -10 | 4,086,127 | -4.3 % |
| 2024Q4 | 93 | +36 | 4,269,154 | +33.5 % |
| 2024Q3 | 57 | +18 | 3,197,181 | +11.2 % |
| 2024Q2 | 39 | 2,875,597 |
Institutional managers
107 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| Alpha Wave Global, LP | 3,707,757 | 83.4M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 2,723,196 | 61.2M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 2,064,075 | 46.4M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 2,009,893 | 45.2M $ | as of Mar 31, 2026 |
| Spruce Street Capital LP | 1,325,210 | 29.1M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 1,101,874 | 24.8M $ | as of Mar 31, 2026 |
| Vivo Capital, LLC | 1,035,551 | 23.3M $ | as of Mar 31, 2026 |
| ARMISTICE CAPITAL, LLC | 912,000 | 20.5M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 821,982 | 18.5M $ | as of Mar 31, 2026 |
| 72 Investment Holdings, LLC | 667,778 | 15M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 666,188 | 15M $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 515,000 | 11.6M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 503,087 | 11.3M $ | as of Mar 31, 2026 |
| Venrock Adviser, LLC | 500,000 | 11.2M $ | as of Mar 31, 2026 |
| Integral Health Asset Management, LLC | 500,000 | 11.2M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 500,000 | 11.2M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 486,726 | 10.9M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 473,403 | 10.6M $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 386,426 | 8.7M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 385,000 | 8.7M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 371,208 | 8.3K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 292,899 | 6.6M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 238,498 | 5.4M $ | as of Mar 31, 2026 |
| ALKEON CAPITAL MANAGEMENT LLC | 227,101 | 5.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 216,099 | 4.9M $ | as of Mar 31, 2026 |
Declared shareholders of Alto Neuroscience Inc
4 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Commodore Capital LP and 3 others | 9.90 % | 3,588,180 | as of Mar 31, 2026 · SCHEDULE 13G |
| Sirenia Capital Management LP and 1 other | 7.90 % | 2,591,587 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vestal Point Capital, LP and 1 other | 6.50 % | 2,064,075 | as of Mar 31, 2026 · SCHEDULE 13G |
| Point72 Asset Management, L.P. and 5 others | 3.70 % | 1,170,865 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding Alto Neuroscience Inc". https://titelia.com/en/stocks/alto-neuroscience-inc-US02157Q1094